Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Photodynamic efficacy of cercosporin in 3D tumor cell cultures.

Grigalavicius M, Mastrangelopoulou M, Arous D, Juzeniene A, Ménard M, Skarpen E, Berg K, Theodossiou TA.

Photochem Photobiol. 2020 Mar 3. doi: 10.1111/php.13257. [Epub ahead of print]

PMID:
32125700
2.

Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study.

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE.

Clin Epidemiol. 2020 Feb 21;12:193-202. doi: 10.2147/CLEP.S241249. eCollection 2020.

3.

Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer.

Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH.

J Labelled Comp Radiopharm. 2020 Mar;63(3):129-143. doi: 10.1002/jlcr.3825. Epub 2020 Jan 29.

PMID:
31919866
4.

Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.

Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE.

BMJ Open. 2019 Feb 20;9(2):e025246. doi: 10.1136/bmjopen-2018-025246.

5.

Antitumor Activity of Novel Bone-seeking, α-emitting 224Ra-solution in a Breast Cancer Skeletal Metastases Model.

Juzeniene A, Bernoulli J, Suominen M, Halleen J, Larsen RH.

Anticancer Res. 2018 Apr;38(4):1947-1955.

PMID:
29599310
6.

Molecular Mechanisms of UVA-Induced Melanoma.

Pudroma X, Duoji G, Grigalavicius M, Jie D, Juzeniene A.

J Environ Pathol Toxicol Oncol. 2017;36(3):217-228. doi: 10.1615/JEnvironPatholToxicolOncol.2017020213. Review.

PMID:
29283335
7.

Endosome Targeting meso-Tetraphenylchlorin-Chitosan Nanoconjugates for Photochemical Internalization.

Gaware VS, Håkerud M, Juzeniene A, Høgset A, Berg K, Másson M.

Biomacromolecules. 2017 Apr 10;18(4):1108-1126. doi: 10.1021/acs.biomac.6b01670. Epub 2017 Mar 15.

PMID:
28245649
8.

The influence of photodynamic therapy with 5-aminolevulinic acid on senescent skin cancer cells.

Grigalavicius M, Juraleviciute M, Kwitniewski M, Juzeniene A.

Photodiagnosis Photodyn Ther. 2017 Mar;17:29-34. doi: 10.1016/j.pdpdt.2016.10.008. Epub 2016 Oct 21.

PMID:
27777143
9.

Phototherapy and vitamin D.

Juzeniene A, Grigalavicius M, Juraleviciute M, Grant WB.

Clin Dermatol. 2016 Sep-Oct;34(5):548-55. doi: 10.1016/j.clindermatol.2016.05.004. Epub 2016 May 20. Review.

PMID:
27638432
10.

Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?

Grant WB, Karras SN, Bischoff-Ferrari HA, Annweiler C, Boucher BJ, Juzeniene A, Garland CF, Holick MF.

Dermatoendocrinol. 2016 May 16;8(1):e1187349. doi: 10.1080/19381980.2016.1187349. eCollection 2016 Jan-Dec. Review.

11.

Layer Thickness of SPF 30 Sunscreen and Formation of Pre-vitamin D.

Grigalavicius M, Iani V, Juzeniene A.

Anticancer Res. 2016 Mar;36(3):1409-15.

PMID:
26977044
12.

Folic acid and its photoproducts, 6-formylpterin and pterin-6-carboxylic acid, as generators of reactive oxygen species in skin cells during UVA exposure.

Juzeniene A, Grigalavicius M, Ma LW, Juraleviciute M.

J Photochem Photobiol B. 2016 Feb;155:116-21. doi: 10.1016/j.jphotobiol.2016.01.001. Epub 2016 Jan 6.

PMID:
26780587
13.

Daily, seasonal, and latitudinal variations in solar ultraviolet A and B radiation in relation to vitamin D production and risk for skin cancer.

Grigalavicius M, Moan J, Dahlback A, Juzeniene A.

Int J Dermatol. 2016 Jan;55(1):e23-8. doi: 10.1111/ijd.13065. Epub 2015 Nov 6.

PMID:
26547141
14.

MRSA decontamination using octenidine-based products.

Danilevicius M, Juzéniené A, Juzénaité-Karneckiené I, Veršinina A.

Br J Nurs. 2015 Aug 13-Sep 19;24(15):S36, S38-40. doi: 10.12968/bjon.2015.24.Sup15.S36.

PMID:
26266563
15.

Supramolecular nanoscale assemblies for cancer diagnosis and therapy.

Coelho SC, Pereira MC, Juzeniene A, Juzenas P, Coelho MAN.

J Control Release. 2015 Sep 10;213:152-167. doi: 10.1016/j.jconrel.2015.06.034. Epub 2015 Jul 6. Review.

PMID:
26160308
16.

Vitamin D and ultraviolet phototherapy in Caucasians.

Grigalavicius M, Moan J, Dahlback A, Juzeniene A.

J Photochem Photobiol B. 2015 Jun;147:69-74. doi: 10.1016/j.jphotobiol.2015.03.009. Epub 2015 Mar 23.

PMID:
25846579
17.

Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females.

Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J.

Scand J Public Health. 2015 May;43(3):324-30. doi: 10.1177/1403494815572206. Epub 2015 Mar 4.

PMID:
25740614
18.

Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas.

Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J.

Anticancer Res. 2015 Feb;35(2):1171-80.

PMID:
25667508
19.

The relationship between UV exposure and incidence of skin cancer.

Moan J, Grigalavicius M, Baturaite Z, Dahlback A, Juzeniene A.

Photodermatol Photoimmunol Photomed. 2015 Jan;31(1):26-35. doi: 10.1111/phpp.12139. Epub 2014 Oct 13.

PMID:
25213656
20.

Ultraviolet-radiation and health: optimal time for sun exposure.

Moan J, Grigalavicius M, Dahlback A, Baturaite Z, Juzeniene A.

Adv Exp Med Biol. 2014;810:423-8.

PMID:
25207380
21.

Sun exposure and melanomas on sun-shielded and sun-exposed body areas.

Juzeniene A, Baturaite Z, Moan J.

Adv Exp Med Biol. 2014;810:375-89. Review.

PMID:
25207377
22.

Minimal and maximal incidence rates of skin cancer in Caucasians estimated by use of sigmoidal UV dose-incidence curves.

Juzeniene A, Grigalavicius M, Baturaite Z, Moan J.

Int J Hyg Environ Health. 2014 Nov;217(8):839-44. doi: 10.1016/j.ijheh.2014.06.002. Epub 2014 Jun 17.

PMID:
25023193
23.

North-South gradients of melanomas and non-melanomas: A role of vitamin D?

Moan J, Grigalavicius M, Baturaite Z, Juzeniene A, Dahlback A.

Dermatoendocrinol. 2013 Jan 1;5(1):186-91. doi: 10.4161/derm.23791.

24.

Biologically efficient solar radiation: Vitamin D production and induction of cutaneous malignant melanoma.

Grigalavicius M, Juzeniene A, Baturaite Z, Dahlback A, Moan J.

Dermatoendocrinol. 2013 Jan 1;5(1):150-8. doi: 10.4161/derm.22941.

25.

Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.

Juzeniene A, Iani V, Moan J.

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):538-45. doi: 10.1016/j.pdpdt.2013.05.008. Epub 2013 Jun 25.

PMID:
24284108
26.

Sunbed use and cutaneous melanoma in Norway.

Moan JE, Baturaite Z, Grigalavicius M, Juzeniene A.

Scand J Public Health. 2013 Dec;41(8):812-7. doi: 10.1177/1403494813496601. Epub 2013 Aug 1.

PMID:
23907734
27.

The action spectrum for folic acid photodegradation in aqueous solutions.

Juzeniene A, Thu Tam TT, Iani V, Moan J.

J Photochem Photobiol B. 2013 Sep 5;126:11-6. doi: 10.1016/j.jphotobiol.2013.05.011. Epub 2013 Jun 7.

PMID:
23892004
28.

Increase in serum 25-hydroxyvitamin-D3 in humans after sunbed exposures compared to previtamin D3 synthesis in vitro.

Orlova T, Moan J, Lagunova Z, Aksnes L, Terenetskaya I, Juzeniene A.

J Photochem Photobiol B. 2013 May 5;122:32-6. doi: 10.1016/j.jphotobiol.2013.03.006. Epub 2013 Mar 28.

PMID:
23591142
29.

Photodegradation of cobalamins in aqueous solutions and in human blood.

Juzeniene A, Nizauskaite Z.

J Photochem Photobiol B. 2013 May 5;122:7-14. doi: 10.1016/j.jphotobiol.2013.03.001. Epub 2013 Mar 14.

PMID:
23558034
30.

Cutaneous malignant melanoma incidence rates in Norway.

Moan J, Baturaite Z, Grigalavicius M, Juzeniene A.

Scand J Public Health. 2013 Jun;41(4):336-9. doi: 10.1177/1403494813479216. Epub 2013 Feb 25.

PMID:
23439631
31.

Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients.

Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE.

Melanoma Res. 2012 Dec;22(6):460-5. doi: 10.1097/CMR.0b013e3283599cc3.

PMID:
23010822
32.

Beneficial effects of UV radiation other than via vitamin D production.

Juzeniene A, Moan J.

Dermatoendocrinol. 2012 Apr 1;4(2):109-17. doi: 10.4161/derm.20013.

33.

Dynamics of signaling, cytoskeleton and cell cycle regulation proteins in glioblastoma cells after sub-lethal photodynamic treatment: antibody microarray study.

Uzdensky A, Kristiansen B, Moan J, Juzeniene A.

Biochim Biophys Acta. 2012 Jul;1820(7):795-803. doi: 10.1016/j.bbagen.2012.03.008. Epub 2012 Mar 20.

PMID:
22484521
34.

Reply to "Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials".

Juzeniene A, Grant WB, Moan JE.

Scand J Infect Dis. 2012 Sep;44(9):712-3. doi: 10.3109/00365548.2012.658580. Epub 2012 Mar 4. No abstract available.

PMID:
22385298
35.

Immediate pigment darkening: its evolutionary roles may include protection against folate photosensitization.

Moan J, Nielsen KP, Juzeniene A.

FASEB J. 2012 Mar;26(3):971-5. doi: 10.1096/fj.11-195859. Epub 2011 Dec 9.

PMID:
22159146
37.

Bioimpedance for pain monitoring during cutaneous photodynamic therapy: Preliminary study.

Mikolajewska P, Rømoen OT, Martinsen OG, Iani V, Moan J, Grimnes S, Juzeniene A.

Photodiagnosis Photodyn Ther. 2011 Dec;8(4):307-13. doi: 10.1016/j.pdpdt.2011.06.001. Epub 2011 Aug 15.

PMID:
22122917
38.

Vitamin D, sun, sunbeds and health.

Moan J, Baturaite Z, Juzeniene A, Porojnicu AC.

Public Health Nutr. 2012 Apr;15(4):711-5. doi: 10.1017/S1368980011002801. Epub 2011 Oct 24. Review.

PMID:
22017922
39.

Comparison of the time and latitude trends of melanoma incidence in anorectal region and perianal skin with those of cutaneous malignant melanoma in Norway.

Micu E, Juzeniene A, Moan J.

J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1444-9. doi: 10.1111/j.1468-3083.2011.04023.x. Epub 2011 Mar 9.

PMID:
21995584
40.

UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden.

Moan J, Baturaite Z, Porojnicu AC, Dahlback A, Juzeniene A.

Photochem Photobiol Sci. 2012 Jan;11(1):191-8. doi: 10.1039/c1pp05215b. Epub 2011 Oct 11.

PMID:
21986949
41.

Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway.

Juzeniene A, Micu E, Porojnicu AC, Moan J.

J Eur Acad Dermatol Venereol. 2012 Jul;26(7):821-7. doi: 10.1111/j.1468-3083.2011.04162.x. Epub 2011 Jun 28.

PMID:
21707773
42.

Photodynamic therapy of cancer: an update.

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J.

CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81. doi: 10.3322/caac.20114. Epub 2011 May 26. Review.

43.

Seasonal variations of cancer incidence and prognosis.

Moan J, Lagunova Z, Bruland O, Juzeniene A.

Dermatoendocrinol. 2010 Apr;2(2):55-7. doi: 10.4161/derm.2.2.12664.

44.

[UV-A radiation and melanomas].

Juzeniene A, Moan J.

Tidsskr Nor Laegeforen. 2011 Feb 18;131(4):333; author reply 333-4. doi: 10.4045/tidsskr.10.1124. Norwegian. No abstract available.

45.

Reflectance spectroscopy and fluorescein angiography applied to assess photodynamic response in healthy mouse skin treated with topical hexylaminolevulinate.

Juzeniene A, Juzenas P, Iani V, Moan J.

Photodiagnosis Photodyn Ther. 2010 Dec;7(4):239-45. doi: 10.1016/j.pdpdt.2010.07.001. Epub 2010 Jul 31.

PMID:
21112546
46.

The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D.

Juzeniene A, Ma LW, Kwitniewski M, Polev GA, Lagunova Z, Dahlback A, Moan J.

Int J Infect Dis. 2010 Dec;14(12):e1099-105. doi: 10.1016/j.ijid.2010.09.002. Epub 2010 Oct 29.

47.

Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy.

Kwitniewski M, Moan J, Juzeniene A.

Photochem Photobiol Sci. 2011 Jan;10(1):25-8. doi: 10.1039/c0pp00193g. Epub 2010 Oct 26.

PMID:
20978658
48.

Solar radiation and human health.

Moan J, Juzeniene A.

J Photochem Photobiol B. 2010 Nov 3;101(2):109-10. doi: 10.1016/j.jphotobiol.2010.08.004. No abstract available.

PMID:
20833325
49.

Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries.

Grant WB, Juzeniene A, Moan JE.

Scand J Public Health. 2011 Feb;39(1):70-8. doi: 10.1177/1403494810382473. Epub 2010 Sep 3. Review.

PMID:
20817654
50.

Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors.

Juzenas P, Juzeniene A.

Photodiagnosis Photodyn Ther. 2010 Sep;7(3):152-7. doi: 10.1016/j.pdpdt.2010.06.003. Epub 2010 Aug 6.

PMID:
20728838

Supplemental Content

Loading ...
Support Center